These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15377696)

  • 1. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.
    Miwa K; Shinoda J; Yano H; Okumura A; Iwama T; Nakashima T; Sakai N
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1457-62. PubMed ID: 15377696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
    Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
    Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met-PET uptake index for total tumor resection: identification of
    Inoue A; Ohnishi T; Kohno S; Ohue S; Nishikawa M; Suehiro S; Matsumoto S; Ozaki S; Fukushima M; Kurata M; Kitazawa R; Shigekawa S; Watanabe H; Kunieda T
    Neurosurg Rev; 2021 Feb; 44(1):587-597. PubMed ID: 32060762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative volumetric analysis of primary glioblastoma multiforme on MRI and 11C-methionine PET: initial study on five patients.
    Zhao J; Chen Z; Cai L; Yin S; Yang W; Wang Z
    Neurol Neurochir Pol; 2019; 53(3):199-204. PubMed ID: 30855705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of nuclide accumulation spread based on the volume of enhancing magnetic resonance imaging lesion in glioblastoma patients.
    Nakayama N; Yamada T; Yano H; Takei H; Ohe N; Miwa K; Shinoda J; Iwama T
    J Neurosurg Sci; 2024 Apr; 68(2):164-173. PubMed ID: 34647709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
    Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
    Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
    Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
    J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
    Galldiks N; Ullrich R; Schroeter M; Fink GR; Jacobs AH; Kracht LW
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):84-92. PubMed ID: 19662410
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tanaka H; Yamaguchi T; Hachiya K; Miwa K; Shinoda J; Hayashi M; Ogawa S; Nishibori H; Goshima S; Matsuo M
    Rep Pract Oncol Radiother; 2018; 23(3):215-219. PubMed ID: 29760596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
    Matsuo M; Miwa K; Shinoda J; Kako N; Nishibori H; Sakurai K; Yano H; Iwama T; Kanematsu M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):714-22. PubMed ID: 19095373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
    Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
    J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Reardon DA; Coleman RE
    Mol Imaging Biol; 2006; 8(6):340-7. PubMed ID: 17051323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging.
    Prada F; Vitale V; Del Bene M; Boffano C; Sconfienza LM; Pinzi V; Mauri G; Solbiati L; Sakas G; Kolev V; D'Incerti L; DiMeco F
    Radiology; 2017 Oct; 285(1):242-249. PubMed ID: 28562204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy.
    Kawasaki T; Miwa K; Shinoda J; Asano Y; Takei H; Ikegame Y; Yokoyama K; Yano H; Iwama T
    World Neurosurg; 2019 May; 125():93-100. PubMed ID: 30716494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.
    Wang Y; Rapalino O; Heidari P; Loeffler J; Shih HA; Oh K; Mahmood U
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1024-1028. PubMed ID: 29913253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.